NEWPORT NEWS, Va., April 6, 2016 /PRNewswire/ -- DILON Diagnostics and GE Healthcare are pleased to announce that they will present GE Healthcare's FDA 510k pending dual head MBI localization accessory for breast biopsy at the SBI/ACR Breast Imaging Symposium. The Annual meeting will be held in Austin, Texas, and the exhibit hall will be open from April 7 to 9. The MBI localization accessory will be presented at the Dilon booth number 209. This important milestone in the breast imaging segment comes shortly after Dilon and GE signed an agreement for DILON to distribute GE's Discovery NM750b Molecular Breast Imaging system in select geographies across the globe.
The Discovery NM750b breast imaging system, designed to measure and image the distribution of selected single photon emission radioisotopes in the human body to aid in the evaluation of lesions, offers clinicians an important tool for imaging of a broad range of patients, including those with dense breast. The MBI localization accessory is a complementary technology to the Discovery NM750b breast imaging system which is designed to accurately locate, in three dimensions, lesions in the breast using information derived from stereotactic pairs of two-dimensional images. It is intended to provide guidance for interventional purposes such as biopsy and pre-surgical.
The power of functional imaging to see and localize early changes is a key factor in early detection of breast cancer.
*510k pending at FDA. Not for sale in the United States. Not CE Marked. Not cleared, approved or authorized by any national regulatory authorities for commercial availability.
About DILON Diagnostics
DILON Diagnostics, a brand of DILON Technologies, Inc., located in Newport News, Virginia, designs, manufactures and commercializes innovative medical imaging solutions worldwide. DILON's cornerstone product, the DILON Molecular Imaging System, is a high-resolution, compact camera for imaging small body parts, such as the breast, thyroid, parathyroid and bone. The DILON Molecular Imaging System has been optimized to perform Molecular Breast Imaging (MBI/BSGI) procedure that aids in the effective management of suspicious and difficult-to-interpret breast cases. For more information on DILON Diagnostics please visit www.dilon.com.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information visit our website www.gehealthcare.com
Media contact: Pjerin Luli
SOURCE DILON Diagnostics